According to Curevac's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.8922. At the end of 2023 the company had a P/S ratio of 33.3.
Year | P/S ratio | Change |
---|---|---|
2023 | 33.3 | 108.24% |
2022 | 16.0 | -70.31% |
2021 | 53.8 | -79.18% |
2020 | 259 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |